Document is current

Any future updates will be listed below

814 DT-9081, a selective EP<sub>4</sub> receptor antagonist which synergizes with immune checkpoint inhibitors to induce complete responses in syngeneic murine cancer models

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0814

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark